Daily Sabah – Following an earlier announcement by Health Minister Fahrettin Koca that Russia’s Sputnik V COVID-19 vaccine will soon be available in the country, a Turkish company has said it is planning to mass-produce the jab in the coming months.
Pharmaceutical firm Viscoran İlaç will produce the coronavirus vaccine at its plants, with manufacturing to launch in the upcoming months, the company said in a joint statement with the Russian Direct Investment Fund (RDIF) Monday.
In comments published in a joint statement, Kirill Dmitriev, CEO of RDIF, said “agreement with Viscoran İlaç provides for increasing our production capabilities and facilitating supplies of Sputnik V globally. We have reached agreements with the leading pharmaceutical producers in a number of countries of Asia, Latin America, Europe and the Commonwealth of Independent States (CIS), and thanks to these partnerships the safe and effective Russian vaccine will be available for people in more than 60 countries.”
“In addition to production agreements, licensing processes, as well as storage and distribution matters, the execution of some clinical studies on the product is also part of our cooperation with Russia for the Sputnik V vaccine. Our studies on this matter continue very successfully as well. We are very pleased to have contributed to such a valuable product that is discussed in the international arena,” Öztürk Oran, chairman of the board at Turkish company said.
As part of the agreement with RDIF, Viscoran İlaç provides assistance in establishing partnerships with other leading local pharmaceutical producers. Technology transfer is currently being finalized with CinnaGen İlaç company, while negotiations with two other production facilities are in process in order to increase the overall capacity.
Read the full story on Daily Sabah
